1 Lucrative Stock Worth Watching and 2 We Steer Clear Of

Profitability Isn’t Everything

While earning profits is crucial, it doesn't ensure a company's future success. Businesses that become complacent with their profit margins may find themselves outpaced as rivals become more aggressive. As Jeff Bezos once remarked, "Your margin is my opportunity."

Although strong earnings are important, they are just one part of the equation. At StockStory, our goal is to help you spot companies with genuine long-term potential. With that in mind, we highlight one consistently profitable company worth your attention, as well as two others that may be better avoided.

Two Stocks to Consider Selling

CSX (CSX)

Latest 12-Month GAAP Operating Margin: 32.1%

CSX (NASDAQ:CSX) is a freight rail operator formed from the merger of the Chessie System and Seaboard Coast Line Industries, focusing on transportation services across the United States.

Reasons We Expect CSX to Lag Behind:

• Unit sales have remained stagnant for two years, indicating that price reductions may be necessary to drive growth.
• Over the past two years, earnings per share have declined at a faster rate than revenue, suggesting diminishing profitability per sale.
• Free cash flow margin has fallen by 18 percentage points in the last five years, signaling increased capital requirements as competition intensifies.

Currently, CSX trades at $42.37 per share, reflecting a forward price-to-earnings ratio of 23.1.

Bunge Global (BG)

Latest 12-Month GAAP Operating Margin: 1.8%

Bunge Global (NYSE:BG), with roots dating back to 1818, operates worldwide to balance seasonal harvests. The company processes oilseeds, grains, and other crops into products such as vegetable oils, protein meals, flours, and specialty ingredients.

Why We’re Cautious About BG:

• Annual revenue growth of just 1.5% over the past three years lags behind other consumer staples companies.
• Earnings per share have dropped by 19.1% per year over the same period, even as revenue increased, indicating that new sales are less profitable.
• Weak liquidity could force the company to raise additional capital, potentially diluting existing shareholders.

Bunge Global is currently priced at $120.18 per share, with a forward P/E of 14.9.

One Stock Worth Watching

Cardinal Health (CAH)

Latest 12-Month GAAP Operating Margin: 1%

Since 1979, Cardinal Health (NYSE:CAH) has played a vital role in the healthcare supply chain, distributing pharmaceuticals and manufacturing medical products for hospitals, pharmacies, and healthcare providers worldwide.

Why Cardinal Health Stands Out

• With $244.7 billion in revenue, Cardinal Health commands significant bargaining power and resilience in a sector with high entry barriers.
• Projected revenue growth of 10.6% over the next year outpaces its recent two-year trend, suggesting accelerating demand.
• Over the past five years, earnings per share have increased by 10.2% annually, outperforming industry peers.

Cardinal Health is trading at $231.85 per share, corresponding to a forward P/E of 20.9. Is now the right time to invest?

Even More Compelling Stocks

ALSO RECOMMENDED: Top 5 Momentum Stocks. The ideal moment to invest in a standout stock is when the market begins to recognize its potential. These companies not only have strong fundamentals, but are also experiencing significant momentum right now.

Discover which stocks our AI-driven platform is highlighting this week. Access the latest Strong Momentum stocks for free.

Our 2020 picks included well-known names like Nvidia, which soared 1,326% from June 2020 to June 2025, as well as lesser-known companies such as Tecnoglass, which delivered a 1,754% five-year return.